New condom material tested for safety and comfort
NCT ID NCT06079060
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new synthetic nitrile condom against a standard latex condom in 305 couples. Each couple used both types five times to see how often they broke or slipped. The goal was to see if the new condom works as well as latex for preventing sexually transmitted diseases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
305 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Oct 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Be between the ages of 18 and 45 years (inclusive); 2. Be literate (able to read a newspaper or letter easily); 3. Have been in an exclusive (monogamous) sexual relationship with partner for at least 3 months; and intend to continue to be an exclusive (monogamous) sexual relationship with their spouse or partner while participating in this research study; 4. Be sexually active (defined as having at least one vaginal coital act per week); 5. Willing to give informed consent; 6. Willing to complete the male condom coital use reports; 7. Willing to use the study condoms as directed; 8. Agree to use only the study lubricant provided; 9. Agree to only use the study condoms sequentially during time of participation 10. Willing to adhere to the follow-up schedule and all study procedures; 11. Willing to provide research study staff with an address, phone number or other locator information while participating in the study; 12. Willing to participate in the study for the duration of 10 condom uses (approximately 2-3 months); 13. Willing to provide photo identification and/or have fingerprint scan to exclude co-enrolment in other research projects; 14. Female partner using hormonal or other non-barrier contraception (e.g. OCs, injectable, implant, Intrauterine device (IUD), or have had a tubal sterilization) or male partner vasectomised; 15. Agree to return any unopened condoms; 16. Male partner willing to ejaculate during vaginal intercourse; 17. Male partner willing to hold on to the condom ring when withdrawing the erect penis after sexual intercourse; 18. Agree to not bring study condoms in contact with genital or oral piercing jewelry 19. EAH: Both partners have valid personal email and operable mobile phones; 20. Former participant in Karex02 Study: male partner measures at least 118 mm in girth of erect penis. 21. Agree that information provided in Karex02 study may be used and combined with the information in this study Exclusion Criteria: 1. Female partner is pregnant or desires to become pregnant during the time of the research study; 2. Either partner is known to be HIV positive (based on self report \[EAH\] or documented HIV-negative test result within past two months; 3. Self-reported history of recurrent sexually transmitted infection (e.g. gonorrhea, syphilis, Chlamydia); 4. Male partner has known erectile or ejaculatory dysfunction; 5. Either partner has genital piercing jewelry, uses genital beading or uses sex toys, drugs, medications or non-study devices that can affect sexual performance; 6. Either partner has known sensitivities or allergies to latex, synthetic nitrile, vaginal/sexual lubricants or lubricants used on condoms; 7. Either partner reports symptoms of STI (EAH) or has observable evidence of STI as determined through syndromic diagnosis and vaginal/penile examination (MRU); 8. Either partner is currently participating in another condom study; 9. Either partner is a past or current employee of Essential Access Health, University of the Witwatersrand, or Karex; 10. Either partner is a sex worker.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sexually transmitted diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Essential Access Health
Berkeley, California, 94710, United States
-
Essential Access Health
Los Angeles, California, 90010, United States
-
MRU (MatCH Research Unit)
Durban, 4000, South Africa
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- HPV infections in transgender people: a hidden health gap gets a closer look
- A tablet tool may empower women to prevent HIV — trial puts it to the test
- Peer navigators and mobile clinics aim to slash HIV rates in rural south african youth
- Could a home urine test revolutionize STI screening for men?
- Can a Mother-Daughter workshop cut HIV rates in teen girls?
- Can a quick chat in a family planning clinic curb risky drinking and drug use?